Champions Oncology (CSBR) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.03 --0%
Financial Fact:
Translational oncology solutions: 3.16M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Translational oncology solutions: 3.16M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.7 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
- Hesai Group (HSAI) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
